BioTech Nation ... with Dr. Moira Gunn cover art

BioTech Nation ... with Dr. Moira Gunn

BioTech Nation ... with Dr. Moira Gunn

By: Moira Gunn
Listen for free

LIMITED TIME OFFER | £0.99/mo for the first 3 months

Premium Plus auto-renews at £8.99/mo after 3 months. Terms apply.

About this listen

 Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.Tech Nation Media Biological Sciences Economics Leadership Management & Leadership Science
Episodes
  • A Fast-Acting Dupixent? Dr. Barry Quart, CEO, Connect Biopharma

    A Fast-Acting Dupixent? Dr. Barry Quart, CEO, Connect Biopharma
    Jan 11 2026

    This is the 2026 BioTech Nation "5":
    Five Companies Ready to Make a Difference.
    We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco.
    Hear all 5 interviews at     https://www.biotechnation.com/jpm-2026-btn-5


    On this episode of BioTech Nation, Moira speaks with Dr. Barry Quart, CEO of Connect Biopharma, about a new fast-acting treatment for inflammatory conditions like Asthma, COPD, and Eczema. Often, these conditions can be managed with anti-inflammatory therapeutics like Dupixent, but even then, sudden and painful flare-ups can occur. We take a closer look at a new anti-inflammatory in late-stage development which starts working quickly, much needed when those flare-ups develop.

    For more information about BioTech Nation and the companies featured here, visit: TechNation.com
    Show More Show Less
    11 mins
  • A Speedy Intervention for Heart Attacks, Dr. Harry Selker & Dr. Atul Deshpande, Immediate Therapeutics

    A Speedy Intervention for Heart Attacks, Dr. Harry Selker & Dr. Atul Deshpande, Immediate Therapeutics
    Jan 13 2026

    This is the 2026 BioTech Nation "5":
    Five Companies Ready to Make a Difference.
    We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco.
    Hear all 5 interviews at     https://www.biotechnation.com/jpm-2026-btn-5


    On this episode of BioTech Nation...
    Dr. Harry Selker & Dr. Atul Deshpande of Immediate Therapeutics speak with Moira about a new treatment that could be administered to heart attack patients right away...potentially before they even arrive at the hospital. Already successfully tested in Phase 2, it’s ready to go into final pivotal trials in Ambulances and Emergency Rooms.

    For more information about BioTech Nation and the companies featured here, visit: TechNation.com
    Show More Show Less
    21 mins
  • A Euphoria-Suppressing Opioid, Ketan Mehta, Founder & CEO, Tris Pharma

    A Euphoria-Suppressing Opioid, Ketan Mehta, Founder & CEO, Tris Pharma
    Jan 11 2026

    This is the 2026 BioTech Nation "5":
    Five Companies Ready to Make a Difference.
    We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco.
    Hear all 5 interviews at     https://www.biotechnation.com/jpm-2026-btn-5


    On this episode of BioTech Nation...
    Ever wonder what makes opioids so addictive? Moira speaks with Ketan Mehta, Founder and CEO of Tris Pharma, about opioid-induced euphoria...and an opioid that's actually meant to suppress this response.

    For more information about BioTech Nation and the companies featured here, visit: TechNation.com
    Show More Show Less
    16 mins
No reviews yet